🔗 Share this article

An underground economy for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, according to new investigations.

Investigational Treatment Gaining Popularity Online

The experimental drug, which remains in research studies, is being advertised by social media influencers for its alleged weight-reducing properties. Followers are encouraged to message these profiles privately for supplier links, while also obtaining promotional offers.

Active Commerce on Messaging Platforms

Separately, a robust market exists on Telegram, where communities with thousands of participants share “before and after” images, administration instructions and assertions of rapid UK delivery. Vendors market the substance there before directing customers to other platforms for purchases.

Understanding The Experimental Drug

Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help individuals reduce up to 25% of their total weight. Referred to as the “triple G”, the substance is being hailed digitally as the successor to Ozempic.

Medical Experts Voice Concerns

Nevertheless, physicians and chemists have warned that the sale of what is still an unlicensed medication in the UK is worrisome and could result in individuals administering products of unknown origin.

Several professionals stated the demand for the experimental drug could be connected to the rising cost of licensed slimming products such as Mounjaro.

Legal Status and Implementation

Selling the unapproved drug on TikTok or Telegram is illegal in the United Kingdom, as it is an unlicensed drug that must not be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Some content creators try to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and distribution can still violate pharmaceutical, marketing, and customer regulations, risking penalties, prosecution or prison.

Service Reaction and Material Elimination

Based on TikTok, the platform has taken down violative content and banned associated keywords and search suggestions. The organization stated it was committed to maintaining the service secure and allocating resources in enhancing compliance measures.

Digital Marketplace Activities

Research also discovered groups with up to nine thousand participants marketing retatrutide using Telegram's integrated search feature, which functions like a online catalog. Entering “retatrutide” immediately displays channels with thousands of members, populated with photos of slimming results, positive reviews and detailed instructions for preparing or administering at residence.

Within minutes of joining one community, a vendor posted contact information, where the majority of transactions take place. The vendor sent an instruction manual and guaranteed shipping within two days. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one inquired about weight, health issues or past usage.

Item Details and Pricing

Within these groups, messages show dark colored parcels with Royal Mail labels, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at residence with sterile water, or ready-to-use injectors usually priced at 160 pounds for 20mg. When questioned how long a injector should be used, vendors give conflicting answers ranging from a several days to “depends on your body”.

Service Moderation and Security Measures

A spokesperson for Telegram stated it actively monitored dangerous content on its service including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are injecting materials they cannot confirm. Even if the science behind this drug is sound, these online products may not contain what they claim,” said a pharmacy expert, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to current cost increases for authorized weight-loss drugs such as Mounjaro. “With prices increasing, patients are turning to social media. But counterfeit injections are extremely risky. You cannot know what’s contained or whether the environment they were made in was sterile,” she said.

Her team has previously seen individuals harmed by self-injection from unconfirmed sources. “We recognize the frustration, but buying from messaging apps or WhatsApp is taking chances with your health,” said the doctor. “These materials could be impure or improperly measured.”

Producer Statement

A spokesperson from Eli Lilly said retatrutide was in third stage clinical trials and had not been reviewed or approved by any government authority globally. “Therefore at this time no one can sell [it] for personal consumption,” they explained, noting that any product “falsely representing itself as a company experimental substance not yet approved … may expose users to potentially serious health risks”.